Small Molecule Success Stories
-
From Lab To Tox Batch: A First-Time-Right API Scale-Up
7/2/2026
Gain insight into a first-time-right process that improved yield and scalability, advancing a vascular calcification inhibitor from lab scale to tox and GMP manufacturing for clinical development.
-
Developing A Multi-Drug Combination, Antiparasitic Drug For Dogs
7/1/2026
Looking to bring an innovative animal health product to market? See how we delivered end-to-end formulation development and rapid clinical supply manufacturing for complex multi-API products.
-
Quick, Cost-Effective Large-Scale Compound Synthesis
6/30/2026
Process optimization delivered a scalable, cost-effective synthesis, increasing yield and reducing waste, solvents, and costs while enabling rapid transition from lab to cGMP manufacturing.
-
The Many Benefits Of Outsourcing Stability
6/2/2026
Outsourcing stability testing improved efficiency, reduced costs, and enhanced scalability, enabling robust lifecycle support, regulatory compliance, and optimized resource utilization across programs.
-
Faster Production Of Panbela's Pancreatic Cancer Drug
6/2/2026
Process innovation reduced synthesis steps, increased yield, and improved chiral purity, enabling faster, scalable manufacturing of a pancreatic cancer therapy for clinical and commercial development.
-
Developing A Multi-Drug Antiparasitic For Dogs
6/2/2026
Complex formulation enabled a multi-drug antiparasitic therapy for dogs, achieving stability, palatability, and scalable clinical supply across multiple strengths within accelerated timelines.
-
Fast-Tracking NDA Approval For A Novel Compound To Treat Infections
6/2/2026
Strategic tech transfer and scalable manufacturing enabled rapid NDA approval, delivering registration batches and accelerating commercialization of a novel therapy for drug-resistant infections.
-
Supporting An Oncology Company In A Treatment For A Rare Tumor
6/2/2026
Integrated development enabled efficient RSM synthesis, scale-up, and GMP manufacturing, advancing rare tumor therapies with improved efficiency, quality, and regulatory readiness.
-
How Green Chemistry Initiatives Reduced Cost While Increasing Yield
6/2/2026
Green process redesign improved yield, reduced waste and solvent use, and cut manufacturing costs by 30% while enabling efficient, scalable production of an oncology compound.
-
A Green Synthesis Process For A Growth Promoter Drug For Animals
6/2/2026
Green chemistry redesigned a growth promoter synthesis, cutting waste and costs while boosting yield, efficiency, and sustainability for scalable animal health manufacturing.